Background/Aims This study aimed to identify the risk factors for chronic kidney disease (CKD) and end-stage renal disease (ESRD) following liver transplantation (LT), with a specific focus on tacrolimus levels and intrapatient variability (IPV).
Methods Among the 1,076 patients who underwent LT between 2000 and 2018, 952 were included in the analysis. The tacrolimus doses and levels were recorded every 3 months, and the IPV was calculated using the coefficient of variability. The cumulative incidence rates of CKD and ESRD were calculated based on baseline kidney function at the time of LT. The impact of tacrolimus levels and their IPV on the development of CKD and ESRD was evaluated, and the significant risk factors were identified.
Results Within a median follow-up of 97.3 months, the 5-year cumulative incidence rates of CKD (0.58 vs. 0.24) and ESRD (0.07 vs. 0.01) were significantly higher in the acute kidney injury group than in the normal glomerular filtration rate (GFR) group. In the normal GFR group, the tacrolimus levels were identified as a risk factor for CKD, with a level of ≤4.5 ng/mL suggested as optimal for minimizing the risk of CKD. Furthermore, the IPV of tacrolimus levels and doses emerged as a significant risk factor for CKD development in both groups (p<0.05), with tenofovir disoproxil fumarate also being a risk factor in HBV-infected patients. The IPV of tacrolimus levels was also a significant factor in ESRD development (p<0.05).
Conclusions This study elucidated the optimal tacrolimus trough level and highlighted the impact of IPV on the CKD and ESRD development post-LT.
Citations
Citations to this article as recorded by
Schisandrin B alleviates liver allograft rejection by stabilizing ACOD1 in Kupffer cells to potentiate itaconate-NRF2-mediated suppression of CD8+ T cell chemotaxis Yihua Wang, Dadi Peng, Dengliang Lei, Liqing Jiang, Song Xiang, Qiuying Li, Hong Zhang, Zhongjun Wu, Chao Yu, Tengxiang Chen Phytomedicine.2026; 154: 158031. CrossRef
Enhanced ocular delivery of tacrolimus via cationic nanoliposomes: Mitigating inflammation and rebalancing Th17/Treg responses in dry eye disease Lirui Liu, Dan Chen, Siting Sheng, Xueqi Lin, Huiling Zhao, Chujun Liu, Xiang Chen, Yang Ye, Wen Xu Materials Today Bio.2026; 38: 103248. CrossRef
Rethinking chronic kidney disease risk after liver transplantation Concetto Sessa, Guido Gembillo, Walter Morale World Journal of Transplantation.2026;[Epub] CrossRef
Intrapatient variability of tacrolimus trough level may be not the cause, but an indirect parameter of comorbidities: Editorial on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development foll Jongman Kim Clinical and Molecular Hepatology.2025; 31(2): 589. CrossRef
Correspondence to letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation” Soon Kyu Lee, Jong Young Choi Clinical and Molecular Hepatology.2025; 31(2): e212. CrossRef
Clinical significance and gene prediction of a novel classification system based on tacrolimus concentration-to-dose ratio in the early post-liver transplant period Junwei Fan, Peihao Wen, Liyun Yuan, Yan Xia, Shijie Hu, Xiaoqing Zhang, Zhihai Peng Frontiers in Pharmacology.2025;[Epub] CrossRef
Chronic kidney disease at one year after liver transplantation: Role of changes in immunosuppression over three decades Alejandro Muñoz-Serrano, María Jesús Citores, Andrea Gutiérrez-Villanueva, Víctor Moreno-Torres, Jorge V López-Ibor, Natalia Vicente, Valentín Cuervas-Mons World Journal of Transplantation.2025;[Epub] CrossRef
Outcomes of Highly Urgent ABO-Incompatible Living Donor Liver Transplantation in National Databases Jongman Kim, Sang Jin Kim, Boram Park, Kyunga Kim, YoungRok Choi, Geun Hong, Jun Yong Park, Young Seok Han, Nam-Joon Yi, Seung Heui Hong, Soon-Young Kim, Jungbun Park, Youngwon Hwang, Dong-Hwan Jung Journal of Korean Medical Science.2026;[Epub] CrossRef
Hemodynamic Profile, Clinical Outcomes, and Potential Transplant Candidacy in Patients With Portopulmonary Hypertension Soongu Kwak, Yechan Kim, Doyeon Hwang, Ki Hong Choi, Jeehoon Kang, Jeong Hoon Yang, Hyung-Kwan Kim, Sung-A Chang Korean Circulation Journal.2026;[Epub] CrossRef
Robust Predictive Performance of the SALT‐M Score for Clinical Outcomes in Asian Patients With Acute‐on‐Chronic Liver Failure Kunhee Kim, Seung Hyuk Yim, Jae Geun Lee, Dong Jin Joo, Myoung Soo Kim, Jun Yong Park, Sang Hoon Ahn, Deok‐Gie Kim, Hye Won Lee Alimentary Pharmacology & Therapeutics.2025; 61(1): 168. CrossRef
Impact of Chronic Hepatitis C Virus on Acute Kidney Injury After Living Donor Liver Transplantation Jae Hwan Kim, Kyoung-Sun Kim, Hye-Mee Kwon, Sung-Hoon Kim, In-Gu Jun, Jun-Gol Song, Gyu-Sam Hwang Anesthesia & Analgesia.2025; 141(3): 608. CrossRef
Appropriate timing and interval for surveillance colonoscopy after liver transplantation based on a single-centre experience Dae Gon Ryu, Hongqun Liu, Samuel S Lee, Ki Tae Yoon, Mayur Brahmania Canadian Liver Journal.2025; 8(1): 39. CrossRef
Correspondence to letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation” Soon Kyu Lee, Jong Young Choi Clinical and Molecular Hepatology.2025; 31(2): e212. CrossRef
Correspondence to editorial on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation” Soon Kyu Lee, Jong Young Choi Clinical and Molecular Hepatology.2025; 31(2): e161. CrossRef
Emergency living donor liver transplantation Jongman Kim Annals of Liver Transplantation.2025; 5(1): 27. CrossRef
Number of Pretransplant Therapeutic Plasma Exchange Sessions Increase the Recurrence Risk of Hepatocellular Carcinoma in ABO-Incompatible Living Donor Liver Transplantation Young Jin Yoo, Deok-Gie Kim, Eun-Ki Min, Seung Hyuk Yim, Mun Chae Choi, Hwa-Hee Koh, Minyu Kang, Jae Geun Lee, Myoung Soo Kim, Dong Jin Joo Transplant International.2025;[Epub] CrossRef
Predicting risk factors for waiting mortality in adult emergent living donor liver transplantation based on Korean national data Sang Jin Kim, Jongman Kim, Kyunga Kim, Soon-Young Kim, Jung-Bun Park, Youngwon Hwang, Dong-Hwan Jung Annals of Liver Transplantation.2025; 5(2): 107. CrossRef
Living versus deceased donor liver transplantation in highly urgent patients using Korean national data Jongman Kim, Sang Jin Kim, Kyunga Kim, YoungRok Choi, Geun Hong, Jun Yong Park, Young Seok Han, Nam-Joon Yi, Soon-Young Kim, Jung-Bun Park, Youngwon Hwang, Dong-Hwan Jung Annals of Liver Transplantation.2025; 5(2): 115. CrossRef
Liver Transplantation at a Small Volume Center—The Role of Network System Chang Ho Seo, Ho Joong Choi, Gun Hyung Na Transplantation Proceedings.2024; 56(3): 653. CrossRef
Approach to Liver Transplantation: Is There a Difference between East and West? Nazli Begum Ozturk, Nathanial Bartosek, Merih Deniz Toruner, Aymen Mumtaz, Cem Simsek, Doan Dao, Behnam Saberi, Ahmet Gurakar Journal of Clinical Medicine.2024; 13(7): 1890. CrossRef
Anastomosis selection in liver transplantation for recipients with unusable recipient hepatic arteries: a bayesian network meta-analysis Warsinggih, Citra Aryanti, Julianus Aboyaman Uwuratuw, Erwin Syarifuddin, Ronald Erasio Lusikooy, Muhammad Faruk BMC Surgery.2024;[Epub] CrossRef
Mortality and associated factors among patients who underwent liver transplantation in South Korea from 2017 to 2021: a retrospective observational study Tak Kyu Oh, In-Ae Song Annals of Surgical Treatment and Research.2024; 107(5): 245. CrossRef
Chronological improvements of living donor liver transplantation for hepatocellular carcinoma in Seoul National University Hospital Saran Ochir Gongor, Kwang-Woong Lee, Nam-Joon Yi, YoungRok Choi, Suk Kyun Hong, Jeong-Moo Lee, Jae-Yoon Kim, Kyung-Suk Suh Annals of Liver Transplantation.2024; 4(2): 71. CrossRef
Outcomes of living donor liver transplantation in patients with concurrent extrahepatic malignancy John Hee Park, Jongman Kim, Sunghyo An, Namkee Oh, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh Annals of Liver Transplantation.2024; 4(2): 102. CrossRef
How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease Byeong Geun Song, Dong Hyun Sinn Clinical and Molecular Hepatology.2023; 29(2): 411. CrossRef
Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation Jeong-Ju Yoo, Jong-In Chang, Ji Eun Moon, Dong Hyun Sinn, Sang Gyune Kim, Young Seok Kim Liver Transplantation.2023; 29(10): 1029. CrossRef
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Takashi Niizeki, Takumi Kawaguchi Clinical and Molecular Hepatology.2023; 29(3): 593. CrossRef
The Effect of Model for End-Stage Liver Disease 3.0 on Disparities between Patients with and without Hepatocellular Carcinoma in Korea Kunhee Kim, Deok-Gie Kim, Jae Geun Lee, Dong Jin Joo, Hye Won Lee Yonsei Medical Journal.2023; 64(11): 647. CrossRef
Comparison of Fibrinogen Concentrate and Cryoprecipitate on Major Thromboembolic Events after Living Donor Liver Transplantation Jae-Hwan Kim, Kyoung-Sun Kim, Hye-Mee Kwon, Sung-Hoon Kim, In-Gu Jun, Jun-Gol Song, Gyu-Sam Hwang Journal of Clinical Medicine.2023; 12(23): 7496. CrossRef
The first successful report of liver transplantation from category III donation after circulatory death in South Korea: a case report Incheon Kang, Jae-myeong Lee, Jae Geun Lee Korean Journal of Transplantation.2022; 36(4): 294. CrossRef
First
Prev
